Clinical Trial

QIPB in Hip Surgery

Completed
View on ClinicalTrials.gov →
Summary
In this single-center retrospective study, patients who underwent hip surgery between May 2025 and November 2025, with American Society of Anesthesiology (ASA) physical status I-III, aged 18 years and older, were screened. Patients who did not undergo a block for postoperative analgesia and who used patient-controlled analgesia were included in the control group. Patients who underwent QIPB and used patient-controlled analgesia were included in the block group. Patients' postoperative tramadol consumption, pain scores assessed using the Numerical Rating Scale, and rescue analgesia requirements were recorded. The primary endpoint was total opioid consumption over 24 hours, and the secondary endpoints were postoperative pain scores and rescue analgesia requirements.
Trial Details
NCT Number NCT07540676
Lead Sponsor Istanbul Medeniyet University
Conditions Hip Surgeries
Enrollment 60 participants
Start Date 2025-05-01
Primary Completion 2025-10-30 (estimated)
Study Completion 2025-11-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-20